• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉骨骼症状与 COVID-19 患者实验室检查结果的关系。

Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19.

机构信息

Physical Medicine and Rehabilitation, Selcuk University Faculty of Medicine, Konya, Turkey.

Biostatistics, Selcuk University Faculty of Medicine, Konya, Turkey.

出版信息

Int J Clin Pract. 2021 Jun;75(6):e14135. doi: 10.1111/ijcp.14135. Epub 2021 Mar 14.

DOI:10.1111/ijcp.14135
PMID:33686741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8250333/
Abstract

AIM

To investigate the frequency of fatigue and musculoskeletal symptoms and their correlation with laboratory data in patients with COVID-19.

METHODS

This study included 80 patients hospitalised and treated for COVID-19 in the infectious diseases clinic between March 2020 and May 2020. Data analysis was performed retrospectively from the hospital medical charts. Demographic data, clinical symptoms, and laboratory findings were noted. Clinical symptoms and correlations with laboratory results were assessed. Besides, an analysis of patients with and without chronic disease was performed for clinical symptoms and laboratory findings.

RESULTS

The frequencies of myalgia and fatigue were 46.1% and 50%, respectively. In the laboratory data, there was a significant increase in creatinine kinase (CK) level and lymphocyte count in the patients with myalgia symptoms (P < .05). There were no other significant results in the laboratory data. Of the patients with chronic disease, it has been shown that hemoglobin levels were significantly decreased (P < .05), while D-dimer was markedly increased (P < .05).

CONCLUSION

The laboratory findings of COVID-19-related myalgia suggested that patients might have a risk of progressive muscle injury. Therefore, these patients should also be followed up in terms of the myopathic process.

摘要

目的

研究 COVID-19 患者疲劳和肌肉骨骼症状的频率及其与实验室数据的相关性。

方法

本研究纳入了 2020 年 3 月至 5 月期间在传染病诊所住院和治疗 COVID-19 的 80 名患者。从医院病历中进行回顾性数据分析。记录人口统计学数据、临床症状和实验室发现。评估临床症状及其与实验室结果的相关性。此外,还对有和没有慢性病的患者进行了临床症状和实验室发现的分析。

结果

肌肉疼痛和疲劳的发生率分别为 46.1%和 50%。在实验室数据中,有肌肉疼痛症状的患者肌酸激酶(CK)水平和淋巴细胞计数显著升高(P<.05)。实验室数据中没有其他显著结果。对于有慢性病的患者,血红蛋白水平显著降低(P<.05),而 D-二聚体明显升高(P<.05)。

结论

COVID-19 相关肌肉疼痛的实验室发现表明患者可能有肌肉损伤进展的风险。因此,这些患者也应在肌病过程方面进行随访。

相似文献

1
Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19.肌肉骨骼症状与 COVID-19 患者实验室检查结果的关系。
Int J Clin Pract. 2021 Jun;75(6):e14135. doi: 10.1111/ijcp.14135. Epub 2021 Mar 14.
2
Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19.评估 COVID-19 住院患者的肌肉骨骼疼痛、疲劳和握力。
Eur J Phys Rehabil Med. 2021 Aug;57(4):653-662. doi: 10.23736/S1973-9087.20.06563-6. Epub 2021 Jan 4.
3
Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎的临床与实验室特征相关性的系统评价和荟萃分析。
Int J Environ Res Public Health. 2020 Jul 13;17(14):5026. doi: 10.3390/ijerph17145026.
4
Non-Respiratory Symptoms of Patients Infected with SARS-CoV-2 (Coronavirus Disease 2019): Lessons from Their Initial Presentation at the Hospital.新型冠状病毒肺炎(COVID-19)患者的非呼吸道症状:来自其在医院首次就诊时的经验教训
Medicina (Kaunas). 2021 Apr 2;57(4):344. doi: 10.3390/medicina57040344.
5
Musculoskeletal symptoms and related factors in postacute COVID-19 patients.急性新冠病毒感染后患者的肌肉骨骼症状及相关因素。
Int J Clin Pract. 2021 Nov;75(11):e14734. doi: 10.1111/ijcp.14734. Epub 2021 Aug 18.
6
Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study.因严重急性呼吸综合征冠状病毒 2 感染而住院时出现的肌肉痛是与持续性肌肉骨骼疼痛相关的新冠长期后遗症的一个症状:一项病例对照研究。
Pain. 2021 Dec 1;162(12):2832-2840. doi: 10.1097/j.pain.0000000000002306.
7
[Clinical and laboratory characteristics of 215 cases of coronavirus disease 2019 with different prognosis].215例不同预后的2019冠状病毒病患者的临床和实验室特征
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Dec;32(12):1428-1433. doi: 10.3760/cma.j.cn121430-20200824-00590.
8
Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.基于临床病程的 COVID-19 患者死亡风险因素:一项单中心回顾性病例对照研究。
Front Immunol. 2021 Feb 16;12:581469. doi: 10.3389/fimmu.2021.581469. eCollection 2021.
9
Analysis of factors for disease progression in 61 patients with COVID-19 in Xiaogan, Hubei, China.中国湖北孝感 61 例 COVID-19 患者疾病进展的因素分析。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12490-12499. doi: 10.26355/eurrev_202012_24045.
10
What are the factors that affect post COVID 1st month's continuing symptoms?影响新冠后 1 个月持续症状的因素有哪些?
Int J Clin Pract. 2021 Nov;75(11):e14778. doi: 10.1111/ijcp.14778. Epub 2021 Sep 12.

引用本文的文献

1
The Role of Serum Prolidase Activity, MMP-1, MMP-7, and TGF-β Values in the Prediction of Early Fibrosis in Patients with Moderate to Severe COVID-19.血清脯氨酰肽酶活性、基质金属蛋白酶-1、基质金属蛋白酶-7和转化生长因子-β值在中重度新型冠状病毒肺炎患者早期纤维化预测中的作用
Viruses. 2025 Jul 6;17(7):954. doi: 10.3390/v17070954.
2
Significance of Neurological Manifestations and Their Association With Clinical Outcomes in Hospitalized COVID-19 Patients in Bandar Abbas, Iran: A Cross-Sectional Study.伊朗阿巴斯港住院COVID-19患者神经学表现的意义及其与临床结局的关联:一项横断面研究
Health Sci Rep. 2025 Apr 18;8(4):e70723. doi: 10.1002/hsr2.70723. eCollection 2025 Apr.
3
Advance in the mechanism and clinical research of myalgia in long COVID.新冠后综合征肌痛的机制与临床研究进展
Am J Clin Exp Immunol. 2024 Aug 25;13(4):142-164. doi: 10.62347/TXVO6284. eCollection 2024.
4
Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches.共病与长新冠之间的相互作用:挑战和多学科方法。
Biomolecules. 2024 Jul 11;14(7):835. doi: 10.3390/biom14070835.
5
Multidisciplinary Management Strategies for Long COVID: A Narrative Review.长新冠的多学科管理策略:一项叙述性综述
Cureus. 2024 May 1;16(5):e59478. doi: 10.7759/cureus.59478. eCollection 2024 May.
6
Post-COVID Pain Is Not Associated with Inflammatory Polymorphisms in People Who Had Been Hospitalized by COVID-19.新冠后疼痛与因新冠病毒病住院患者的炎症多态性无关。
J Clin Med. 2022 Sep 25;11(19):5645. doi: 10.3390/jcm11195645.
7
Lifting the Mask on Musculoskeletal Manifestations of COVID-19: Results of an Interview-Based Study.揭开 COVID-19 肌肉骨骼表现的面纱:一项基于访谈研究的结果
Open Access Rheumatol. 2022 Oct 4;14:211-220. doi: 10.2147/OARRR.S376289. eCollection 2022.
8
Musculoskeletal symptoms in patients with long COVID: A cross-sectional study on Iranian patients.新冠长期症状患者的肌肉骨骼症状:一项针对伊朗患者的横断面研究。
Heliyon. 2022 Aug;8(8):e10148. doi: 10.1016/j.heliyon.2022.e10148. Epub 2022 Aug 11.
9
Prevalence of Neuropathic Component in Post-COVID Pain Symptoms in Previously Hospitalized COVID-19 Survivors.新冠后疼痛症状中神经病理性成分在既往住院 COVID-19 幸存者中的流行率。
Int J Clin Pract. 2022 Mar 16;2022:3532917. doi: 10.1155/2022/3532917. eCollection 2022.
10
The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection.轻度至中度新冠病毒感染后的肌肉骨骼受累情况
Front Physiol. 2022 Mar 18;13:813924. doi: 10.3389/fphys.2022.813924. eCollection 2022.

本文引用的文献

1
Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients.新型冠状病毒肺炎(COVID-19)患者的肌肉骨骼症状
J Orthop Surg Res. 2020 May 18;15(1):178. doi: 10.1186/s13018-020-01702-w.
2
Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France.老年患者的临床特征:法国一家专门收治新冠肺炎老年患者的短期住院病房的经验。
J Infect. 2020 Jul;81(1):e93-e94. doi: 10.1016/j.jinf.2020.04.009. Epub 2020 Apr 17.
3
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.风湿病学家对 2019 冠状病毒病(COVID-19)的看法和潜在治疗靶点。
Clin Rheumatol. 2020 Jul;39(7):2055-2062. doi: 10.1007/s10067-020-05073-9. Epub 2020 Apr 10.
4
High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China.中国江苏 COVID-19 感染患者的高分辨率胸部 CT 特征和临床特征。
Int J Infect Dis. 2020 Jun;95:106-112. doi: 10.1016/j.ijid.2020.04.003. Epub 2020 Apr 6.
5
Tocilizumab treatment in COVID-19: A single center experience.托珠单抗治疗 COVID-19:单中心经验。
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
6
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital.方仓医院中新型冠状病毒感染(COVID-19)非危重症患者的临床特征。
Clin Microbiol Infect. 2020 Aug;26(8):1063-1068. doi: 10.1016/j.cmi.2020.03.032. Epub 2020 Apr 3.
7
Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain.玻利维亚首例和一组源自意大利和西班牙的 2019 冠状病毒病(COVID-19)病例的临床特征。
Travel Med Infect Dis. 2020 May-Jun;35:101653. doi: 10.1016/j.tmaid.2020.101653. Epub 2020 Apr 2.
8
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.85 例武汉 COVID-19 死亡病例的临床特征。一项回顾性观察研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379. doi: 10.1164/rccm.202003-0543OC.
9
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.综述文章:COVID-19 的胃肠道特征和粪便传播的可能性。
Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
10
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征:回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.